Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 2
2015 1
2018 1
2021 1
2022 5
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.
Calviño C, Ceballos C, Alfonso A, Jauregui P, Calleja-Cervantes ME, San Martin-Uriz P, Rodriguez-Marquez P, Martin-Mallo A, Iglesias E, Abizanda G, Rodriguez-Diaz S, Martinez-Turrillas R, Illarramendi J, Viguria MC, Redondo M, Rifon J, Villar S, Lasarte JJ, Inoges S, Lopez-Diaz de Cerio A, Hernaez M, Prosper F, Rodriguez-Madoz JR. Calviño C, et al. Among authors: villar s. Front Immunol. 2023 Sep 19;14:1270843. doi: 10.3389/fimmu.2023.1270843. eCollection 2023. Front Immunol. 2023. PMID: 37795087 Free PMC article.
Updates on the Management of Acute Myeloid Leukemia.
Huerga-Domínguez S, Villar S, Prósper F, Alfonso-Piérola A. Huerga-Domínguez S, et al. Among authors: villar s. Cancers (Basel). 2022 Sep 29;14(19):4756. doi: 10.3390/cancers14194756. Cancers (Basel). 2022. PMID: 36230677 Free PMC article. Review.
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Simoes C, Villar S, Ariceta B, Garcés JJ, Burgos L, Alignani D, Sarvide S, Martínez-Cuadrón D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez-Lorenzo JL, Vidriales MB, Chillon C, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Pierola AA, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MÁ, Paiva B, Montesinos P; PETHEMA cooperative study group. Simoes C, et al. Among authors: villar s. Br J Haematol. 2023 Jun;201(6):1239-1244. doi: 10.1111/bjh.18815. Epub 2023 Apr 14. Br J Haematol. 2023. PMID: 37057357 No abstract available.
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia.
Simoes C, Chillon MC, Martínez-Cuadrón D, Calasanz MJ, Vridiales MB, Vazquez I, Hernández-Ruano M, Ariceta B, Aguirre-Ruiz P, Burgos L, Alignani D, Sarvide S, Villar S, Pierola AA, Prosper F, Ayala R, Martínez-López J, Bergua Burgues JM, Vives S, Perez-Simon JA, Garcia-Fortes M, Bernal Del Castillo T, Colorado M, Olave M, Rodríguez-Gutiérrez JI, Labrador J, González M, San-Miguel JF, Sanz MÁ, Montesinos P, Paiva B. Simoes C, et al. Among authors: villar s. Blood Adv. 2023 Jan 10;7(1):167-173. doi: 10.1182/bloodadvances.2022008141. Blood Adv. 2023. PMID: 36240453 Free PMC article.
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia.
Stölzel F, Fordham SE, Nandana D, Lin WY, Blair H, Elstob C, Bell HL, Mohr B, Ruhnke L, Kunadt D, Dill C, Allsop D, Piddock R, Soura EN, Park C, Fadly M, Rahman T, Alharbi A, Wobus M, Altmann H, Röllig C, Wagenführ L, Jones GL, Menne T, Jackson GH, Marr HJ, Fitzgibbon J, Onel K, Meggendorfer M, Robinson A, Bziuk Z, Bowes E, Heidenreich O, Haferlach T, Villar S, Ariceta B, Diaz RA, Altschuler SJ, Wu LF, Prosper F, Montesinos P, Martinez-Lopez J, Bornhäuser M, Allan JM. Stölzel F, et al. Among authors: villar s. JCI Insight. 2023 Jan 24;8(2):e150368. doi: 10.1172/jci.insight.150368. JCI Insight. 2023. PMID: 36480300 Free PMC article.
[AIDS Study Group/Spanish AIDS Consensus Plan Document on sexually transmitted infections in HIV-infected patients].
Panel de expertos del Grupo de Estudio de Sida (GESIDA) y del Plan Nacional sobre el Sida (PNS). Panel de expertos del Grupo de Estudio de Sida (GESIDA) y del Plan Nacional sobre el Sida (PNS). Enferm Infecc Microbiol Clin. 2011 Apr;29(4):286.e1-19. doi: 10.1016/j.eimc.2010.10.002. Epub 2011 Mar 17. Enferm Infecc Microbiol Clin. 2011. PMID: 21419527 Spanish.
Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic Transplantation.
Valle-Arroyo J, Páez-Vega A, Fernández-Moreno R, López-Jiménez J, Luna A, Duarte R, Serrano-Martínez F, Villar S, Fernández-Alonso M, Reina G, González-Rico C, Fariñas MC, Rojas R, Herrera C, Martín C, García-Torres E, Torre-Cisneros J, Cantisán S. Valle-Arroyo J, et al. Among authors: villar s. Transplant Cell Ther. 2022 Oct;28(10):703.e1-703.e8. doi: 10.1016/j.jtct.2022.07.005. Epub 2022 Jul 11. Transplant Cell Ther. 2022. PMID: 35830929 Free article.
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial.
Simoes C, Paiva B, Martínez-Cuadrón D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MÁ, Montesinos P. Simoes C, et al. Among authors: villar s. Blood Adv. 2021 Feb 9;5(3):760-770. doi: 10.1182/bloodadvances.2020003195. Blood Adv. 2021. PMID: 33560390 Free PMC article. Clinical Trial.
19 results